You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.0 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 0.9 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 0.10 | -4.10 | -3.45p | -3.8 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | n/a | -4.79 | -3.53p | -1.7 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -17.73 | -9.46p | -16.2 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -57.86 | -24.28p | -8.6 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -20.09 | -8.76p | -1.5 | 0.0 | n/a | n/a | 0.0% |
Synairgen posts positive results for phase 2 trial with SNG001 against Covid-19 Sharecast News | 04 Oct |
---|---|
Synairgen unveils positive clinical trial data Sharecast News | 07 Sep |
Synairgen to collaborate with University of Southampton on observational study Sharecast News | 05 Sep |
Posting of Annual Report and Notice of AGM | 23-May-23 14:48 |
---|---|
2022 Full Year Results | 27-Apr-23 15:51 |
Notice of Full Year results | 17-Apr-23 14:52 |
Second Price Monitoring Extn | 13-Mar-23 23:59 |
Price Monitoring Extension | 13-Mar-23 23:59 |